AFF2
Basic information
Region (hg38): X:148500617-149000663
Previous symbols: [ "FMR2" ]
Links
Phenotypes
GenCC
Source: 
- FRAXE intellectual disability (Strong), mode of inheritance: XL
- FRAXE intellectual disability (Supportive), mode of inheritance: XL
- FRAXE intellectual disability (Definitive), mode of inheritance: XL
- non-syndromic X-linked intellectual disability (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Premature ovarian failure | XL | Obstetric | Genetic knowledge may be beneficial to allow interventions such as preserving eggs in women with premature ovarian insufficiency | Endocrine; Neurologic; Obstetric | 8334699; 8023854; 7536393; 7783162; 8673085; 8651274; 9341861; 9475603; 10528856; 12605436; 19136466; 21739600 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_provided (203 variants)
- Inborn_genetic_diseases (106 variants)
- FRAXE (50 variants)
- not_specified (39 variants)
- AFF2-related_disorder (21 variants)
- Intellectual_disability (4 variants)
- Non-syndromic_X-linked_intellectual_disability (3 variants)
- Intellectual_disability,_moderate (1 variants)
- Myopia (1 variants)
- Hirsutism (1 variants)
- Premature_ovarian_failure (1 variants)
- Short_stature (1 variants)
- Hypotonia (1 variants)
- Primary_microcephaly (1 variants)
- Synophrys (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AFF2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002025.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 36 | 46 | ||||
| missense | 218 | 45 | 269 | |||
| nonsense | 4 | |||||
| start loss | 0 | |||||
| frameshift | 4 | |||||
| splice donor/acceptor (+/-2bp) | 7 | |||||
| Total | 6 | 11 | 226 | 81 | 6 | 
Highest pathogenic variant AF is 0.000006638084
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| AFF2 | protein_coding | protein_coding | ENST00000370460 | 21 | 500055 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 0.996 | 0.00423 | 125735 | 4 | 8 | 125747 | 0.0000477 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.41 | 413 | 502 | 0.823 | 0.0000379 | 8652 | 
| Missense in Polyphen | 183 | 237.35 | 0.77103 | 4184 | ||
| Synonymous | -1.05 | 205 | 187 | 1.10 | 0.0000145 | 2582 | 
| Loss of Function | 4.98 | 5 | 38.2 | 0.131 | 0.00000281 | 689 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.000263 | 0.000234 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.000145 | 0.000109 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.0000505 | 0.0000352 | 
| Middle Eastern | 0.000145 | 0.000109 | 
| South Asian | 0.0000575 | 0.0000327 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
- FUNCTION: RNA-binding protein. Might be involved in alternative splicing regulation through an interaction with G-quartet RNA structure. {ECO:0000269|PubMed:19136466}.;
Recessive Scores
- pRec
- 0.280
Intolerance Scores
- loftool
- 0.205
- rvis_EVS
- -1.08
- rvis_percentile_EVS
- 7.2
Haploinsufficiency Scores
- pHI
- 0.317
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0786
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Aff2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;mRNA processing;brain development;learning or memory;RNA splicing;regulation of gene expression;negative regulation of gene expression;nuclear speck organization;regulation of RNA splicing
- Cellular component
- nucleus;transcription elongation factor complex;nuclear speck;ELL-EAF complex
- Molecular function
- G-quadruplex RNA binding;double-stranded DNA binding;DNA-binding transcription factor activity